• Control iPSC Differentiated Cells
    • Parental line available
    • Male or female donors
    Control iPSC Differentiated Cells

iPSC Differentiated Cells

We offer fully characterized progenitors and differentiated cell lines derived from integration-free iPSCs using feeder-free culture protocols: Neural stem cells (NSCs), Neurons (Dopaminergic and Cortical neurons), Astrocytes, Microglia and Cardiomyocytes.

The cell lines have been characterized for the expression of characteristic biomarkers using immunohistochemistry and for functional viability. Our isogenic panel of neural lineage cells have also been validated by whole genome profiling to ensure cellular integrity and quality. 

These cell lines are ideal for various applications in biomedical and applied research:

  • Disease Modeling
  • Drug target discovery
  • Neurotoxicity and cardiotoxicity drug screening
  • Drug efficacy testing for new neurological drug candidates
  • Cell-based therapeutic research
iPSC Differentiated Cells Categories

Neural Stem Cell,
Neurons & Astrocytes

Ready-to-use fully characterized Neural Stem Cells (NSCs), astrocytes, and neurons derived from well-characterized control human iPSCs.

Neural Stem Cell,
Neurons & Astrocytes

iPSC-derived Microglia

High purity, integration-free, iPSC-differentiated functional microglia for neuroinflammation, neurodegenerative disease modeling (Alzheimer’s, PD).

iPSC-derived Microglia

iPSC Differentiated
Cardiomyocytes

Ready-to-use, beating iPSC-differentiated human cardiomyocytes differentiated are ideal for functional assessments in cardiac safety drug screening.

iPSC Differentiated
Cardiomyocytes

Publications

iPSC-differentiated cell lines

  • Gupta, G., Gliga, A., Hedberg, J., Serra, A., Greco, D., Odnevall Wallinder, I., & Fadeel, B. Cobalt nanoparticles trigger ferroptosis‐like cell death (oxytosis) in neuronal cells: Potential implications for neurodegenerative disease. The FASEB Journal.
  • Kussauer, S., David, R., & Lemcke, H. (2019). hiPSCs Derived Cardiac Cells for Drug and Toxicity Screening and Disease Modeling: What Micro-Electrode-Array Analyses Can Tell Us. Cells8(11), 1331.
  • Cheng, F., Fransson, L. Å., & Mani, K. (2019). The cyanobacterial neurotoxin β-N-methylamino-l-alanine prevents addition of heparan sulfate to glypican-1 and increases processing of amyloid precursor protein in dividing neuronal cells. Experimental Cell Research. https://doi.org/10.1016/j.yexcr.2019.03.041
  • Daily, N. J., et al. (2017). High-Throughput Phenotyping of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Neurons Using Electric Field Stimulation and High-Speed Fluorescence Imaging. ASSAY and Drug Development Technologies. 15(4): 178-188. https://doi.org/10.1089/adt.2017.781
  • Daily, N. J., Santos, R., Vecchi, J., Kemanli, P., & Wakatsuki, T. (2017). Calcium transient assays for compound screening with human iPSC-derived cardiomyocytes: Evaluating new tools. Journal of evolving stem cell research, 1(2), 1.
  • Daily, N. J., et al. (2015). Journal of Bioengineering & Biomedical Science, 2015.
Have Questions?

An Applied StemCell technical expert is happy to help, contact us today!

Google